Literature DB >> 32376971

High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission.

Matthew J Rees1, Andrew Spencer2, Peter Browett3, Frank Alvaro4, Duncan Purtill5, Julie Crawford6, Sam Milliken7, Hock Lai8, Humphrey Pullon9, Andrew Grigg10.   

Abstract

Entities:  

Year:  2020        PMID： 32376971     DOI： 10.1038/s41409-020-0924-3

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Core binding factor acute myeloid leukemia.

Authors:  Guido Marcucci
Journal:  Clin Adv Hematol Oncol       Date:  2006-05

2.  Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Authors:  C D Bloomfield; D Lawrence; J C Byrd; A Carroll; M J Pettenati; R Tantravahi; S R Patil; F R Davey; D T Berg; C A Schiffer; D C Arthur; R J Mayer
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.